Skip to content
Screener

Artivion AORT Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$113.0MBeat by $5.5M
EPS$0.24Beat by $0.13
Revenue estimate$107.4M
EPS estimate$0.11

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$120.9M
EPS estimate$0.11

Financials

Q2 2025

Income statement

See full
Revenue$113.0M+15.3%
Gross profit$73.1M+15.5%
Operating income$8.4M+28.8%
Net income$1.3M+163%
EPS (diluted)$0.03+160%

Balance sheet

See full
Cash & equivalents$53.5M-2.8%
Total debt$263.7M-27.3%
Total equity$419.9M+42.3%
Total assets$838.4M+6.2%

Cash flow

See full
Operating cash flow$15.0M+145%
CapEx$3.3M+30.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.46B+36.7%
Enterprise value$1.67B+21.4%
P/S3.6×+0.8×

Profitability

See full
Gross margin64%-0.6pp
Operating margin4.3%-4.6pp
Net margin-4.4%+940pp

Returns & leverage

See full
Return on equity-5%+13.7pp
Debt / equity0.6×-0.6×
Current ratio4.8×-0.9×

Segments

By segment

See full
North America$57.6M+18.3%
EMEA$38.7M+13.4%
APAC$11.1M+15.3%
LATAM$5.6M0.0%

By product

See full
Aortic stent grafts$39.8M+23.8%
On-X$25.6M+23.9%
Surgical sealants$19.3M+4.0%
Other$2.7M+49.9%

By geography

See full
UNITED STATES$53.5M—

FAQ

When did Artivion report Q2 2025 earnings?
Artivion (AORT) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Artivion's Q2 2025 revenue and EPS?
Artivion reported revenue of $113.0M and eps of $0.24 for Q2 2025.
Did Artivion beat estimates in Q2 2025?
Revenue beat the consensus estimate of $107.4M by $5.5M. EPS beat the consensus estimate of $0.11 by $0.13.
How did Artivion's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.3% from $98.0M a year earlier and eps grew 242.9% from $0.07.
Where can I find Artivion's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-038873) and the 10-Q periodic report (0001628280-25-039166) directly on SEC EDGAR. The filing index links above go to sec.gov.